Cerevel Therapeutics Holdings, Inc. 3 SEC Filings

Filed On	Filing
28 Jun 2023	Form 3: Burgess Paul D., See Remarks No securities owned
14 Jun 2023	Form 3: Renaud Ronald C Jr, Director No securities owned
19 May 2023	Form 3: Altschuller Susan, Chief Financial Officer No securities owned
22 Jun 2022	Form 3: Varma Suneet, Director No securities owned
20 Sep 2021	Form 3: Pf Equity Holdings 1 B.v., 10% owner Holds 27,349,211 shares of Common Stock
28 May 2021	Form 3: Akamine Scott, Chief Legal Officer No securities owned
13 May 2021	Form 3: Ceesay Abraham, President No securities owned
01 Feb 2021	Form 3: Baron Deborah, Director No securities owned
01 Feb 2021	Form 3: Patrick Deval L, Director No securities owned
11 Dec 2020	Form 3: Mckernan Ruth, Director No securities owned
02 Nov 2020	Form 3: Mishan Orly, Chief Business Officer
02 Nov 2020	Form 3: Birnbaum Morris, Director No securities owned
30 Oct 2020	Form 3: Dekkers Marijn E, Director Holds 28,540 shares of Common Stock
30 Oct 2020	Form 3: Yi Kathy, Chief Financial Officer
30 Oct 2020	Form 3: Renger John, Chief Scientific Officer
30 Oct 2020	Form 3: Giordano Douglas E., Director No securities owned
30 Oct 2020	Form 3: Tregoning Kathleen, See Remarks
30 Oct 2020	Form 3: Sanchez Ramiro, Chief Medical Officer
30 Oct 2020	Form 3: Phillips Bryan K, Chief Legal Officer
30 Oct 2020	Form 3: Riedel Norbert G, Director Holds 14,270 shares of Common Stock

Comments